Literature DB >> 21058024

Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.

Jaroslav Sebestik1, Petr Niederhafner, Jan Jezek.   

Abstract

The size of information that can be stored in nucleic acids, proteins, and carbohydrates was calculated. The number of hexamers for peptides is 64,000,000 (20(6)) and seems to be impressive in comparison with 4,096 (4(6)) hexanucleotides, but the number of isomers of hexasaccharides is 1.44 × 10(15). Carbohydrates are therefore the best high-density coding system. This language has been named glycocode resp. sugar code. In comparison with peptide dendrimers, the amount of information carried by glycopeptide dendrimers or glycodendrimers is therefore much higher. This is reflected by the variability of structures and functions (activities). This review is about the broad area of peptide and glycopeptide dendrimers. The dendrimeric state and physicochemical properties and general consequences are described, together with a cluster effect. The impact of cluster effect to biological, chemical, and physical properties is discussed. Synthesis of dendrimers by convergent and divergent approaches, "Lego" chemistry, ligation strategies, and click chemistry is given with many examples. Purification and characterization of dendrimers by chromatographic methods, electromigration methods, and mass spectrometry are briefly mentioned. Different types of dendrimers with cyclic core, i.e. RAFTs, TASPs and analogous cyclic structures, carbopeptides, carboproteins, octopus glycosides, inositol-based dendrimers, cyclodextrins, calix[4]arenes, resorcarenes, cavitands, and porphyrins are given. Dendrimers can be used for creation of libraries, catalysts, and solubilizing agents. Biocompatibility and toxicity of dendrimers is discussed, as well as their applications in nanoscience, nanotechnology, drug delivery, and gene delivery. Carbohydrate interactions of glycopeptide dendrimers (bacteria, viruses, and cancer) are described. Examples of dendrimers as anti-prion agents are given. Dendrimers represent a fast developing area which partly overlaps with nanoparticles and nanotechnologies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21058024     DOI: 10.1007/s00726-010-0707-z

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  17 in total

Review 1.  The new toxicology of sophisticated materials: nanotoxicology and beyond.

Authors:  Andrew D Maynard; David B Warheit; Martin A Philbert
Journal:  Toxicol Sci       Date:  2010-12-22       Impact factor: 4.849

2.  Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.

Authors:  Jie Liu; Warren D Gray; Michael E Davis; Ying Luo
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

3.  Polymeric conjugates for drug delivery.

Authors:  Nate Larson; Hamidreza Ghandehari
Journal:  Chem Mater       Date:  2012-01-04       Impact factor: 9.811

4.  Nanomedicine for prion disease treatment: new insights into the role of dendrimers.

Authors:  James M McCarthy; Dietmar Appelhans; Jörg Tatzelt; Mark S Rogers
Journal:  Prion       Date:  2013 May-Jun       Impact factor: 3.931

Review 5.  Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.

Authors:  Micah D K Glasgow; Mahavir B Chougule
Journal:  J Biomed Nanotechnol       Date:  2015-11       Impact factor: 4.099

6.  Synthetic glycopeptides and glycoproteins with applications in biological research.

Authors:  Ulrika Westerlind
Journal:  Beilstein J Org Chem       Date:  2012-05-30       Impact factor: 2.883

7.  Comparative toxicological assessment of PAMAM and thiophosphoryl dendrimers using embryonic zebrafish.

Authors:  Joseph B Pryor; Bryan J Harper; Stacey L Harper
Journal:  Int J Nanomedicine       Date:  2014-04-17

Review 8.  Cyclodextrins-Peptides/Proteins Conjugates: Synthesis, Properties and Applications.

Authors:  Jakub Łagiewka; Tomasz Girek; Wojciech Ciesielski
Journal:  Polymers (Basel)       Date:  2021-05-27       Impact factor: 4.329

9.  Multivalent display of the antimicrobial peptides BP100 and BP143.

Authors:  Imma Güell; Rafael Ferre; Kasper Kildegaard Sørensen; Esther Badosa; Iteng Ng-Choi; Emilio Montesinos; Eduard Bardají; Lidia Feliu; Knud J Jensen; Marta Planas
Journal:  Beilstein J Org Chem       Date:  2012-12-03       Impact factor: 2.883

Review 10.  Nanoencapsulation for drug delivery.

Authors:  Avnesh Kumari; Rubbel Singla; Anika Guliani; Sudesh Kumar Yadav
Journal:  EXCLI J       Date:  2014-03-20       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.